Literature DB >> 27773520

Predictive Models for Normal Fetal Cardiac Structures.

Anita Krishnan1, Jodi I Pike1, Robert McCarter1, Amanda L Fulgium1, Emmanuel Wilson1, Mary T Donofrio1, Craig A Sable2.   

Abstract

BACKGROUND: Clinicians rely on age- and size-specific measures of cardiac structures to diagnose cardiac disease. No universally accepted normative data exist for fetal cardiac structures, and most fetal cardiac centers do not use the same standards. The aim of this study was to derive predictive models for Z scores for 13 commonly evaluated fetal cardiac structures using a large heterogeneous population of fetuses without structural cardiac defects.
METHODS: The study used archived normal fetal echocardiograms in representative fetuses aged 12 to 39 weeks. Thirteen cardiac dimensions were remeasured by a blinded echocardiographer from digitally stored clips. Studies with inadequate imaging views were excluded. Regression models were developed to relate each dimension to estimated gestational age (EGA) by dates, biparietal diameter, femur length, and estimated fetal weight by the Hadlock formula. Dimension outcomes were transformed (e.g., using the logarithm or square root) as necessary to meet the normality assumption. Higher order terms, quadratic or cubic, were added as needed to improve model fit. Information criteria and adjusted R2 values were used to guide final model selection.
RESULTS: Each Z-score equation is based on measurements derived from 296 to 414 unique fetuses. EGA yielded the best predictive model for the majority of dimensions; adjusted R2 values ranged from 0.72 to 0.893. However, each of the other highly correlated (r > 0.94) biometric parameters was an acceptable surrogate for EGA. In most cases, the best fitting model included squared and cubic terms to introduce curvilinearity.
CONCLUSIONS: For each dimension, models based on EGA provided the best fit for determining normal measurements of fetal cardiac structures. Nevertheless, other biometric parameters, including femur length, biparietal diameter, and estimated fetal weight provided results that were nearly as good. Comprehensive Z-score results are available on the basis of highly predictive models derived from gestational age or other biometrics as preferable for clinical reasons. These results supplant current equations and will provide a foundation for future multicenter collaborations. Copyright Â
© 2016 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac parameters in the fetus; Fetal echocardiography; Z score

Mesh:

Year:  2016        PMID: 27773520     DOI: 10.1016/j.echo.2016.08.019

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  4 in total

1.  Fetal Echocardiographic Dimension Indices: Important Predictors of Postnatal Coarctation.

Authors:  Katrin Fricke; Petru Liuba; Constance G Weismann
Journal:  Pediatr Cardiol       Date:  2020-12-23       Impact factor: 1.655

2.  Temporal analysis of cardiovascular control and function following incomplete T3 and T10 spinal cord injury in rodents.

Authors:  Kathryn A Harman; Gregory States; Abigail Wade; Chad Stepp; Grace Wainwright; Kathryn DeVeau; Nicholas King; Alice Shum-Siu; David S K Magnuson
Journal:  Physiol Rep       Date:  2018-03

3.  Cardiac Measurements of Size and Shape in Fetuses With Absent or Reversed End-Diastolic Velocity of the Umbilical Artery and Perinatal Survival and Severe Growth Restriction Before 34 Weeks' Gestation.

Authors:  Greggory R DeVore; Percy Pacora Portella; Edgar Hernandez Andrade; Lami Yeo; Roberto Romero
Journal:  J Ultrasound Med       Date:  2020-10-30       Impact factor: 2.754

4.  Normal right and left ventricular volumes prospectively obtained from cardiovascular magnetic resonance in awake, healthy, 0- 12 year old children.

Authors:  Laura J Olivieri; Jiji Jiang; Karin Hamann; Yue-Hin Loke; Adrienne Campbell-Washburn; Hui Xue; Robert McCarter; Russell Cross
Journal:  J Cardiovasc Magn Reson       Date:  2020-02-03       Impact factor: 5.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.